1 / 7

North America Breast Cancer Therapeutics Market Outlook - Industry Statistics An

North America Breast Cancer Therapeutics Market To Hit USD 16 Bn By 2028. Increasing R&D efforts, clinical trial studies, as well as public & private investments in research are likely to power North America breast cancer therapeutics market forecast through 2028. With a goal to improve patient outcomes, leading industry players such as AstraZeneca, Pfizer, Novartis, BMS, Amgen, Merck, and Roche are intently focused on R&D and new product development as their key strategies.

sudeepkedar77
Download Presentation

North America Breast Cancer Therapeutics Market Outlook - Industry Statistics An

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. North America Breast Cancer Therapeutics Market to expand lucratively till 2028 ©2018 Graphical Research. All rights reserved. www.graphicalresearch.com

  2. North America Breast Cancer Therapeutics Market To Hit USD 16 Bn By 2028. Increasing R&D efforts, clinical trial studies, as well as public & private investments in research are likely to power North America breast cancer therapeutics market forecast through 2028. With a goal to improve patient outcomes, leading industry players such as AstraZeneca, Pfizer, Novartis, BMS, Amgen, Merck, and Roche are intently focused on R&D and new product development as their key strategies. • Breast cancer is still the most frequent cancer in women worldwide, and it is also the primary cause of cancer mortality in women. Men, like women, are susceptible to breast cancer, albeit at a far lower incidence. • Targeted breast cancer treatments are one of the most promising areas of breast cancer research. These treatments deliver toxic cancer-killing drugs directly to tumor cells, avoiding the "fallout" harm to healthy cells caused by broad-spectrum chemotherapies and radiation. Speaking of the importance of research in this field, experts believe that the more we learn about the genetic distinctions that exist among tumors, the more targets that can be found. • Recently, the University of California San Francisco's Comprehensive Cancer Center revealed that it is presently conducting clinical studies utilizing immunoliposomes, a novel targeted breast cancer technique. Given the vast potential of the therapy in patient care, North America breast cancer therapeutics industry share from targeted therapy is likely to grow at nearly 7.8% CAGR through 2028. ©2018 Graphical Research. All rights reserved. www.graphicalresearch.com

  3. Get sample copy of this research report @ • https://www.graphicalresearch.com/request/2073/sample • Request for customization @ • https://www.graphicalresearch.com/request/2073/customize-this-report ©2018 Graphical Research. All rights reserved. www.graphicalresearch.com

  4. Cancer vaccinations are now being researched as stand-alone treatments, as well as in conjunction with chemotherapy and immunotherapy. Some of these vaccinations are customized, while others target cancer-cell proteins more broadly. BioNTech and Regeneron Pharmaceuticals, for example, are presently working together on an mRNA cancer vaccine for metastatic melanoma. BNT111 is now in phase 2 clinical trials. • BioNTech was given FDA fast track designation in late 2021 based on clinical results demonstrating the vaccine’s ability to overcome current constraints in the treatment of inoperable therapy-resistant advanced-stage melanoma. • U.S. breast cancer therapeutics industry share accounted for $9.3 billion sales of the total market in 2021. According to the U.S. Breast Cancer Statistics 2022, an anticipated 287,850 new instances of invasive breast cancer will be diagnosed among U.S. women. The high prevalence rates have significantly impacted government investment on cancer care. For instance, in 2016, President Biden introduced the ‘Cancer Moonshot’ with the goal of accelerating cancer research. • In February 2022, he announced a relaunch of the mission, with additional targets such as reducing cancer deaths by at least 50% over the following 25 years. The mission has brought together a large community of investigators and clinicians who are dedicated to accelerating research in order to improve the lives of people with cancer, by focusing on areas of cancer research. The Cancer Moonshot has raised $1.8 billion financing in the seven years since its launch. ©2018 Graphical Research. All rights reserved. www.graphicalresearch.com

  5. Segments of North America Breast Cancer Therapeutics Market ; • North America Market, By Therapy • Targeted Therapy • Hormonal Therapy • Chemotherapy • Immunotherapy ©2018 Graphical Research. All rights reserved. www.graphicalresearch.com

  6. About Graphical Research: Graphical Research is a business research firm that provides industry insights, market forecast and strategic inputs through granular research reports and advisory services. We publish targeted research reports with an aim to address varied customer needs, from market penetration and entry strategies to portfolio management and strategic outlook. We understand that business requirements are unique: our syndicate reports are designed to ensure relevance for industry participants across the value chain. We also provide custom reports that are tailored to the exact needs of the customer, with dedicated analyst support across the purchase lifecycle. Contact Us: Parikhit B. Corporate sales, Graphical Research Email:sales@graphicalresearch.comWeb: https://www.graphicalresearch.com ©2018 Graphical Research. All rights reserved. www.graphicalresearch.com

  7. Stay In Touch With Us For: Website: www.graphicalresearch.com Social Media: Assured Quality On-Time Delivery Payment Security Industry Experts ©2018 Graphical Research. All rights reserved. www.graphicalresearch.com

More Related